A study published in The EMBO Journal opens new perspectives to better understand how the molecular mechanisms involved in regenerative medicine work. The study focuses on tumor necrosis factor-α (TNF ...
New research published in Current Pharmaceutical Analysis delves into the activity of the tumor necrosis factor-alpha (TNF-α) system in patients with central nervous system disorders such as ...
“We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for Translational Medicine. “And TNF-α is still the most contested—and the most ...